Rosser CJ - Search Results

1

Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancer.

Anai S, Sakamoto N, Sakai Y, Tanaka M, Porvasnik S, Urbanek C, Cao W, Goodison S, Rosser CJ. Anai S, et al. Among authors: rosser cj. Urol Oncol. 2011 Jul-Aug;29(4):421-9. doi: 10.1016/j.urolonc.2009.04.009. Epub 2009 Jul 3. Urol Oncol. 2011. PMID: 19576799

2

Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression.

Zhou JH, Rosser CJ, Tanaka M, Yang M, Baranov E, Hoffman RM, Benedict WF. Zhou JH, et al. Among authors: rosser cj. Cancer Gene Ther. 2002 Aug;9(8):681-6. doi: 10.1038/sj.cgt.7700489. Cancer Gene Ther. 2002. PMID: 12136429

3

Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.

Rosser CJ, Tanaka M, Pisters LL, Tanaka N, Levy LB, Hoover DC, Grossman HB, McDonnell TJ, Kuban DA, Meyn RE. Rosser CJ, et al. Cancer Gene Ther. 2004 Apr;11(4):273-9. doi: 10.1038/sj.cgt.7700673. Cancer Gene Ther. 2004. PMID: 14765130

4

PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer.

Tanaka M, Rosser CJ, Grossman HB. Tanaka M, et al. Among authors: rosser cj. Cancer Detect Prev. 2005;29(2):170-4. doi: 10.1016/j.cdp.2004.07.006. Epub 2004 Dec 10. Cancer Detect Prev. 2005. PMID: 15829377

5

p37 Induces tumor invasiveness.

Ketcham CM, Anai S, Reutzel R, Sheng S, Schuster SM, Brenes RB, Agbandje-McKenna M, McKenna R, Rosser CJ, Boehlein SK. Ketcham CM, et al. Among authors: rosser cj. Mol Cancer Ther. 2005 Jul;4(7):1031-8. doi: 10.1158/1535-7163.MCT-05-0040. Mol Cancer Ther. 2005. PMID: 16020660

6

Prostate cancer screening and detection in inner-city and underserved men.

Anai S, Pendleton J, Wludyka P, Williams C, Nelms L, Pettaway C, Rosser CJ. Anai S, et al. Among authors: rosser cj. J Natl Med Assoc. 2006 Apr;98(4):515-9. J Natl Med Assoc. 2006. PMID: 16623063 Free PMC article.

7

Combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts.

Anai S, Goodison S, Shiverick K, Iczkowski K, Tanaka M, Rosser CJ. Anai S, et al. Among authors: rosser cj. Hum Gene Ther. 2006 Oct;17(10):975-84. doi: 10.1089/hum.2006.17.975. Hum Gene Ther. 2006. PMID: 16984224

8

Neoadjuvant therapy before radical prostatectomy: where have we been? Where are we going?

Pendleton J, Pisters LL, Nakamura K, Anai S, Rosser CJ. Pendleton J, et al. Among authors: rosser cj. Urol Oncol. 2007 Jan-Feb;25(1):11-8. doi: 10.1016/j.urolonc.2006.03.005. Urol Oncol. 2007. PMID: 17208133 Review.

9

Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts.

Anai S, Goodison S, Shiverick K, Hirao Y, Brown BD, Rosser CJ. Anai S, et al. Among authors: rosser cj. Mol Cancer Ther. 2007 Jan;6(1):101-11. doi: 10.1158/1535-7163.MCT-06-0367. Mol Cancer Ther. 2007. PMID: 17237270

10

Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.

Rice L, Handayani R, Cui Y, Medrano T, Samedi V, Baker H, Szabo NJ, Rosser CJ, Goodison S, Shiverick KT. Rice L, et al. Among authors: rosser cj. J Nutr. 2007 Apr;137(4):964-72. doi: 10.1093/jn/137.4.964. J Nutr. 2007. PMID: 17374662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters